window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Grifols

  • Biologics & Biosimilars,Hematology,Pharmaceuticals and therapeutics

    Grifols fibrinogen concentrate FESILTY approved in the US for acute bleeding in congenital fibrinogen deficiency

    Grifols has received US Food and Drug Administration (FDA) approval [...]

    January 2, 2026
  • Chronic diseases,Hematology,Pharmaceuticals and therapeutics,Regulatory Affairs

    Grifols secures expanded FDA label for Thrombate to include pediatric hereditary antithrombin deficiency

    Grifols has received US FDA approval for an expanded indication [...]

    November 18, 2025
  • Biologics & Biosimilars,Drug approval,European biotech,Hematology,Rare Diseases

    Grifols’ Biotest secures first approval for fibrinogen concentrate in Germany

    Grifols’ Biotest has received its first regulatory approval for a [...]

    November 14, 2025
  • Biomanufacturing,Pharmaceuticals and therapeutics,Rare Diseases,Regulatory Affairs

    Grifols’ Biotest launches Yimmugo in United States after FDA approval

    Grifols has expanded its portfolio of plasma-derived therapies in the [...]

    October 12, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Delivery & Formulation,Market Access & Commercialization,Partnerships & Funding

    XL-protein grants global licence to Grifols for long-acting biologic using PASylation technology

    PASylated candidate to advance into preclinical development under new agreement [...]

    June 11, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kinesin-2 motor variants shown to control cargo transport in neurons
    Categories: Neurosciences, Research & Development
  • Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome
    Categories: Central Nervous System, Clinical Development, Drug Delivery & Formulation, Drug Development, Neurosciences, Patient Centricity
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top